Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced …

Hyperviscosity syndrome (HVS) recently emerged as a complication of coronavirus disease
2019 (COVID-19) and COVID-19 vaccines. Therefore, the objectives of this critical review …

The aim of this study was to (1) analyze blood viscosity, red blood cell (RBC) deformability,
and aggregation in hospitalized patients with Coronavirus disease 19 (COVID‐19);(2) test …

Clinical syndrome coronavirus disease 2019 (COVID-19) induced by severe acute
respiratory syndrome coronavirus 2 is characterized by rapid spreading and high mortality …

Background: Coronavirus Disease 2019 (COVID-19) was described to affect red blood cells
(RBC) in both severe and mild disease courses. The aim of this study was to investigate …

Although COVID-19 begins as a respiratory pneumonia, we are now discovering it causes
an intense inflammatory response accompanied by systemic microangiopathy. In reflecting …

Low plasma estrogens, vitamin D deficiency, obesity, diabetes, cardiovascular diseases,
thromboembolism, and impaired microcirculation are linked to the severity of covid-19 …

Hematological and hemorheological parameters are known to be altered in COVID-19;
however, the value of combined monitoring in order to deduce disease severity is only …

Infection with the novel severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)
and the associated coronavirus disease‐19 (COVID‐19) might affect red blood cells (RBC); …

COVID-19 is the important global problem. This new coronavirus can cause several
hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19 …